Cynapsus Overview
- Founded
- 2004
- Status
- Acquired/Merged
- Employees
- 30
- Latest Deal Type
- M&A
- Financing Rounds
- 10
- Investments
- 1
Cynapsus General Information
Description
Operator of a specialty central nervous system (CNS) pharmaceutical company. The company develops a sublingual thin film for the potential treatment for on-demand management of debilitating OFF episodes associated with Parkinson's disease. It also completed a Phase two clinical trial for its product candidate, APL-130277, a sublingual formulation of apomorphine hydrochloride, or apomorphine.
Contact Information
Website
Formerly Known As
Cannasat Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- 828 Richmond Street West
- Toronto, Ontario M6J 1C9
- Canada
Cynapsus Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Cynapsus‘s full profile, request access.
Request a free trialCynapsus Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a specialty central nervous system (CNS) pharmaceutical company. The company develops a sublingual thin film
Pharmaceuticals
Toronto, Canada
30
As of 2016
000.00
0000
0000-00-00
000000&0
000.00
0000000
magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
00000 000000000000000 000 0000000000000
New York, NY
00
As of 0000
00000
00000000
00000
00000000
ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000000000000
Trevose, PA
00
As of 0000
00000
0000
0000-00-00
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCynapsus Competitors (26)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Axovant Sciences | Formerly VC-backed | New York, NY | 00 | 00000 | 00000000 | 00000 |
| 000000000000 00000 | Corporate Backed or Acquired | Trevose, PA | 00 | 00000 | 00000000000 | 00000 |
| 00000000 | Formerly VC-backed | Jersey City, NJ | 00 | 00000 | 000000000 | 00000 |
| 00000000 000000000 | Corporation | Givatayim, Israel | 0 | 000.00 | 000000000 | 000.00 |
| 0000 000000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00.000 | 000000000 | 00.000 |
Cynapsus Executive Team (6)
Cynapsus Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 0000000000 | Cynapsus | President, Chief Executive Officer and Director | 000 0000 |
| 000000000 00000000 | Self | Board Member | 000 0000 |
| 000 0000000000 | Cynapsus | Board Member | 000 0000 |
| 00000 00000000 00 | Cynapsus | Board Member | 000 0000 |
| 00000000 00000000 | Cynapsus | Chairman | 000 0000 |
Cynapsus Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCynapsus Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Cynapsus‘s full profile, request access.
Request a free trialCynapsus Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 00000000000 | 22-Dec-2011 | 000000000000000000 | 00.00 | Pharmaceuticals | 00000000 00000000 |